Targeting FOXO1 as an option to treat obesity?

Tobias B. Dansen; E Kalkhoven

doi:10.1080/15384101.2015.1060779

Targeting FOXO1 as an option to treat obesity?

Tobias B. Dansen^*, E Kalkhoven

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Comment on: Zou P, et al. Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 2014; 13(23):3759-67; PMID: 25483084; http://dx.doi.org/10.4161/15384101.2014.965977

Original language	English
Pages (from-to)	2558
Number of pages	1
Journal	Cell Cycle
Volume	14
Issue number	16
DOIs	https://doi.org/10.1080/15384101.2015.1060779
Publication status	Published - 1 Jan 2015

Access to Document

10.1080/15384101.2015.1060779

15Final published version, 380 KB

Cite this

@article{74477671fa194337bcaafb588ba359c8,

title = "Targeting FOXO1 as an option to treat obesity?",

abstract = "Comment on: Zou P, et al. Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 2014; 13(23):3759-67; PMID: 25483084; http://dx.doi.org/10.4161/15384101.2014.965977",

author = "Dansen, {Tobias B.} and E Kalkhoven",

year = "2015",

month = jan,

day = "1",

doi = "10.1080/15384101.2015.1060779",

language = "English",

volume = "14",

pages = "2558",

journal = "Cell Cycle",

issn = "1538-4101",